一个基于模型的元分析框架量化了在亚托皮性皮炎试验中安慰剂反应的驱动因素
Jean C Serrano1, John Maringwa2, Roel Straetemans3
1Johnson & Johnson, Cambridge, Massachusetts, USA.
CPT: pharmacometrics & systems pharmacology
|November 17, 2025
概括
这项研究介绍了一种基于模型的元分析 (MBMA) 针对阿托皮性皮炎 (AD) 临床试验. 它揭示了同时治疗和基线疾病严重程度显著影响安慰剂反应,为更好的试验设计提供了见解.
科学领域:
- 皮肤病学 皮肤病学
- 临床试验 临床试验
- 生物统计学 生物统计学
背景情况:
- 亚托匹性皮肤炎 (AD) 临床试验面临挑战,因为安慰剂反应的高变化性使新疗法的评估变得复杂.
- 现有的元分析使用单个时间点数据,未能捕捉纵向安慰剂反应动态.
研究的目的:
- 开发和应用基于模型的元分析 (MBMA) 框架来分析AD试验中EASI-75安慰剂反应的时间过程预测.
- 在中度至重度AD临床试验中确定影响安慰剂反应变异性的关键共变量.
主要方法:
- 一个系统的文献审查确定了40个2/3期AD试验,其中4827名患者适合纵向建模.
- 使用基于模型的元分析 (MBMA) 来预测EASI-75随时间推移的安慰剂反应,并结合了共变量.
主要成果:
- 同时治疗,特别是局部皮质类固醇 (TCS),增加了EASI-75安慰剂率的1.8倍.
- 较高的基线EASI得分与较低的安慰剂反应率有关 (每增加1个点减少了0.96倍).
- 到第12周,安慰剂反应趋于平稳,第12周的结果反映了第16周预计反应的94%.
结论:
- 在AD试验中,MBMA框架为分析纵向安慰剂反应提供了可靠的方法.
- 这些发现为优化临床试验设计,功率计算和区分治疗效果与安慰剂反应在AD药物开发中提供了定量指导.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
01:54The Placebo Effect
6.8K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.8K
01:11Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
01:20Measurement of Bioavailability: Pharmacodynamic Methods
225
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
225
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
169
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
169
02:07Blind Procedures
12.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.8K